JK
Therapeutic Areas
Cleerly Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cleerly AI-QCT Platform | Coronary Artery Disease Diagnosis & Risk Stratification | FDA-Cleared |
| Cleerly ISCHEMIA | Detection of Vessel-Specific Coronary Ischemia | FDA-Cleared |
Leadership Team at Cleerly
JK
James K. Min, MD
Founder & CEO
JH
Jim Hartman
Chief Commercial Officer
UH
Udo Hoffmann, MD
Chief Medical, Scientific and AI Officer
KM
Kimberly McCombs
Chief Strategy Officer
AR
Amit Relia
Chief Regulatory Officer
AL
Andrew Levitch
Chief Financial Officer
CP
Christine Pellizzari
Chief Legal Officer
MS
Michal Sofka
Chief Technology Officer
SB
Scott Barclay
Board of Directors
OM
Oscar Munoz
Board of Directors